Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

SIRT6 in Longevity and Progeria

Current understanding

SIRT6 is a chromatin-associated sirtuin with deacetylase, mono-ADP-ribosyltransferase, and defatty-acylase activities implicated in DNA repair, heterochromatin maintenance, and metabolic regulation; loss-of-function shortens mouse lifespan while transgenic overexpression extends it (animal-model). Ashkenazi centenarian-enriched SIRT6 missense variants (e.g., N308K/A313S) raise endogenous SIRT6 protein and rebalance its enzymatic activities, and knock-in of these variants in hESC-derived lineages enhances resistance to cellular senescence and progerin stress, with partial phenocopy by AAV-SIRT6 or fucoidan-derived activators in progeria fibroblasts (mechanism-plausible for humans; preclinical). No human outcome data yet — the translation pitch (SIRT6 activator therapeutics for progeria/aging) currently outruns the biology.

Evidence log

Open questions

Related

Contributing findings

pubmed preclinical animal-model
Hepatic SIRT6 Deficiency Accelerates Female-Specific Aging Through SULT1E1-Mediated Estrogen Depletion.
05-aug-2026 novelty 3 per-area 3 strengthens
pubmed preclinical
Centenarian SIRT6 variants elevate SIRT6 protein and enhance cellular senescence resistance.
19-jun-2026 novelty 4 per-area 4 introduces

build build 880 · 2bcef25 · 2026-11-18